Ten Common Questions (and Their Answers) About Off-label Drug Use

Wittich, Christopher M., Burkle, Christopher M., Lanier, William L.·2012·Mayo Clinic Proceedings
DOI 10.1016/j.mayocp.2012.04.017

Cited by (366)

Items 301–366 of 366

  1. ASPECTOS TOXICOLÓGICOS DA RISPERIDONA E SEUS EFEITOS COLATERAIS NO TRATAMENTO DO AUTISMO
    Peter Nillecker Silva de Assis, Tibério César Lima de Vasconcelos, João Gomes Pontes Neto · 2023
  2. Antipsychotics: Past, Present, and Future (Part 2): Article 2 of 3
    Steven A. Levenson · 2024 · The Senior Care Pharmacist
  3. Antipsychotics in Perspective: Past, Present, and Future (Article 2 of 3)
    Steven A. Levenson · 2024 · Journal of the American Medical Directors Association
  4. A custom device for managing recurrent tracheoesophageal voice prosthesis dislodgement and aspiration due to treatment refractory, severely enlarged puncture: A video case report
    Barbara M. Ebersole, Mark Zafereo, Katherine A. Hutcheson · 2024 · Head & Neck
  5. Exploring Off-Label Drug Use Across Medical Specialties
    Virendra Kushwaha, Pooja Agrawal, BK Shoraisham, Mohd Aamir · 2024 · International Journal of Pharmaceutical Sciences Review and Research
  6. Identifying Areas for Development of the Law of Practicing Healthcare Professionals in Saudi Arabia: A Medicolegal Committee-Based Survey Study
    Abdulaziz Mohammed Althunayan, Mana Almuhaideb, Meshari A. Alzahrani, Raed Mohammed Almannie · 2023 · Journal of forensic, science and law.
  7. Reassessing The Data Exclusivity Regime For The Indian Pharmaceutical Industry
    Khushbu Kumari · 2024
  8. The Potential of Ambroxol as a Panacea for Neonatal Diseases: A Scoping Review
    Sameer Yaseen Al-Abdi, Maryam Ali Al-Aamri · 2024 · Cureus
  9. Public Preference for Off-Label Use of Drugs for Cancer Treatment and Relative Importance of Associated Adverse Events: A Discrete Choice Experiment and Best-Worst Scaling
    Kailu Wang, Ho-Man Shum, Carrie Ho‐Kwan Yam, Yushan Wu, Eliza Lai‐Yi Wong, Eng‐Kiong Yeoh · 2024 · Applied Health Economics and Health Policy
  10. Postmarket drug safety monitoring
    Nicklas Sarantos, Benjamin K. Canales · 2024 · Elsevier eBooks
  11. The Sharing and Exchange of Patents
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  12. Copyright
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  13. Alternatives to Intellectual Property
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  14. What Is Innovation?
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  15. Patent Litigation and Enforcement
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  16. Innovation and Competition in Firms
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  17. Strategic Patenting, Patent Portfolio Races, and Patent Thickets
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  18. Intellectual Property Rights and Economic Development
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  19. Illustrations
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  20. Preface
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  21. Supply and Demand for Innovation
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  22. Innovation Policy
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  23. Diffusion
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  24. Returns to R&D and Innovation
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  25. Software, Business and Financial Methods, Open Source, and Artificial Intelligence
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  26. Patent Trolls
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  27. Patents, Utility Models, Design Rights, and Plant Breeder Rights
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  28. Innovation Strategy
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  29. Patents and Pharmaceuticals
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  30. Trademarks and Brands
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  31. Appropriation Mechanisms
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  32. Data
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  33. List of Abbreviations
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  34. Copyright Page
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  35. La prescripción off label
    Estela Azaustre Lago, Cristina Armenteros Gil, Susana Aldecoa Landesa · 2024 · Actualización en Medicina de Familia
  36. Probiotics as potential allies in hormonal harmony and metabolic management: unlocking the Gut- Poly Cystic Ovary Syndrome (PCOS)
    M. Uma Priya, Treesa P. Varghese, Abilash Vijayan, K. Elango, Anish John · 2024 · Research Journal of Pharmacy and Technology
  37. Artifacts: A Presentist Social Functionalist Account (Co-written with Clint Hurshman)
    Armin W. Schulz · 2025 · Springer eBooks
  38. Assessing pharmacy staff practices and knowledge of off-label drug use in Ministry of Health Hospitals, Saudi Arabia: A cross-sectional study
    Mohammed A. Alomary, Norah F. Alshehri, Abdullah M. Alzahrani, Ayed A. Alkatheeri, Maan H. Harbi, M. Almalki, Najwa A. Almutairi, Shikhah G. Aldajani, Dunya M. Emam, Rayan M. Alzahrani et al. · 2025 · Medicine
  39. Marketing and promotion of off-label uses of repetitive transcranial magnetic stimulation treatment
    Lindsay M. Oberman, Andrew F. Leuchter, Sarah Hollingsworth Lisanby · 2025 · Transcranial magnetic stimulation .
  40. Chapter 2: The Drug Approval Process
    Kevin M. Bosse · 2025 · The American Pharmacists Association eBooks
  41. Off-Label Use of Drugs
    Sushil Sharma · 2025 · Introduction to Basics of Pharmacology and Toxicology
  42. Off-label prescribing of tamsulosin: A nationwide retrospective study combining prescription and regulatory data
    Anna Artner, Ákos Niedermüller, Máté Attila Csapó, Nikoletta Ngo Hanh, Emília Fekete, Romána Zelkó, Szilvia Sebők · 2025 · Exploratory Research in Clinical and Social Pharmacy
  43. Physician Perceptions and Intentions in Response to Unsupportive Data for Off-label Uses: An Experimental Study with Primary Care Providers and Oncologists
    Kathryn J. Aikin, Simani M. Price, Amie C. O’Donoghue, Melanie C. Chansky, Roberta Baskin · 2025 · Therapeutic Innovation & Regulatory Science
  44. Off-label use of COVID-19 vaccines was once discouraged but has become common amid new guidelines
    Shannon Fyfe, Elizabeth Lanphier · 2025
  45. Bibliography
    2025 · Elsevier eBooks
  46. Adverse Events of 4% Articaine in Children below 4 Years of Age: An Observational Study
    H Ananthu, Ashwin Rao, Ashwin Kamath, Sumesh T. Rao · 2025 · International Journal of Clinical Pediatric Dentistry
  47. Additional file 1 of Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study
    Melanie C. Chansky, Simani M. Price, Kathryn J. Aikin, Amie C. O’Donoghue · 2022 · Figshare
  48. Additional file 1 of Barriers and facilitators to guideline for the management of pediatric off-label use of drugs in China: a qualitative descriptive study
    Min Meng, Hu, Jiale, Liu, Xiao, Tian, Min, Wenjuan Lei, Liu, Enmei, Han, Zhu, Li, Qiu, Yaolong Chen · 2024 · Figshare
  49. Additional file 2 of Barriers and facilitators to guideline for the management of pediatric off-label use of drugs in China: a qualitative descriptive study
    Min Meng, Hu, Jiale, Liu, Xiao, Tian, Min, Wenjuan Lei, Liu, Enmei, Han, Zhu, Li, Qiu, Yaolong Chen · 2024 · Figshare
  50. Additional file 2 of Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study
    Melanie C. Chansky, Simani M. Price, Kathryn J. Aikin, Amie C. O’Donoghue · 2022 · Figshare
  51. Assessment of off-label use of oral medications in pediatric patients and a novel approach to identify unmet needs in pediatric drug development
    Mami Kobayashi, Mami Segami, Hitomi Wakabayashi, Kenji Momo · 2025 · The Showa Medical University Journal
  52. Ethics of Off-Label Marketing of Drugs: Patient Safety Versus Commercial Profits
    Preetma Kooner, Gail A. Van Norman · 2025 · Springer eBooks
  53. General Principles of Psychopharmacology
    Julian A. Giakas, George Thomas Grossberg · 2026 · Springer eBooks
  54. Tranexamic acid in prehospital emergency medicine: Evidence and availability in Vojvodina
    Ivan Pešić, Ana Kasap, Maksim Zinijakov · 2026 · ABC - časopis urgentne medicine
  55. Notes
    Miranda Yaver · 2026
  56. When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical Responsibilities
    Joshua Mitchell, Benjamin Bregman, Renuka Surujnarain, Dominic A. Sisti, Amy L. McGuire · 2026 · Psychiatric Services
  57. Judicial Adjudication of Medication Provision Disputes During COVID-19 in Brazil: Health Misinformation, Therapeutic Evidence, and Implications for Pharmacovigilance and Public Health Practice
    F M O Fernanda Matos Oliveira, Simone Luzia Fidélis de Oliveira, Alessandra Lima Fontenele, Dirce Guilhem · 2026 · Research Square
  58. Study of prescription-indication of antivirals for herpesviruses in a Colombian population: a cross-sectional study
    Luis Fernando Valladales‐Restrepo, Mariana Velásquez-Echeverry, Mariana Castañeda-Orozco, Sahian Camila Trejos-Gonzáles, Zayra Daniela Tapasco-Hernández, María Paula Cedeño-Ospina, Jorge Enrique Machado‐Alba · 2026 · Expert Review of Anti-infective Therapy
  59. Perspectives
    John D. Cahill, Keith Gallagher · 2026 · Cambridge University Press eBooks
  60. Whether and When to “Get Creative” with Off-Label Use for “Treatment Resistance”
    Robert B. Ostroff · 2026 · Cambridge University Press eBooks
  61. The long shadow of typhoons: Prenatal exposure and adult mental health
    Yu-Ting Huang, Elaine M. Liu, Jin‐Tan Liu, Tzu-Yin Hazel Tseng · 2026 · Journal of Development Economics
  62. Off‐Label Prescribing as Therapeutic Governance: Regulation and Inequality in Contemporary Medicine
    Enrique Fernández Vilas, Raquel Coca-Asensio, David Casado Neira, Manuel Torres‐Cubeiro, Marcos Iglesias Carrera, Juan R. Coca · 2026 · Sociology Lens
  63. Physicians’ Judgments About Off-Label Medical Narcotic Use and Dose Reduction Responses: A South Korean Cross-Sectional Survey
    Yongsoo Lee, Yang‐Ki Minn, Jung Eun Kim · 2026 · Medicina
  64. Determinants of off-label drug acceptance in pregnancy: insights from an extended UTAUT model
    Chunhong Liang, Fayan Que, Pingzhi Peng, Lijuan Zhou, Qian Qiu, Yi Pang, Xueyan Zhang · 2026 · Frontiers in Pharmacology
  65. Off-label drug use in children: prevalence, risks, and regulation
    Antje C. Neubert, Sonja Eberl · 2026 · Expert Review of Clinical Pharmacology
  66. Contrast‐Enhanced Ultrasound: The Case for a Whole‐Body Indication—An Expert Panel Discussion
    Stephanie R. Wilson, R. Graham Barr, Kassa Darge · 2026 · Journal of Ultrasound in Medicine